Wei Deng

2.4k citations

93 papers · 1.4k indexed · h-index 22

Impact in

Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Hematology top 5%
- Acute Myeloid Leukemia Research

Papers in

Obstetrics and Gynecology 10
- Endometrial and Cervical Cancer Treatments 10
Pulmonary and Respiratory Medicine 33
- Gastric Cancer Management and Outcomes 15
- Radiation Therapy and Dosimetry 8

Co-authors: Steven H. Lin Jason Gotlib Timothy Devos Elliott F. Winton Francisco Cervantes Donal P. McLornan Ruben A. Mesa John Catalano
Journals: Gynecologic Oncology (12 papers)Journal of Clinical Oncology (6 papers)Blood (4 papers)Medical Physics (4 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)
Partner nations: China United States Hong Kong

In The Last Decade

Wei Deng

83 papers receiving 1.4k citations

Peers

Countries citing papers authored by Wei Deng

Since Specialization

Citations

This map shows the geographic impact of Wei Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Deng more than expected).

Fields of papers citing papers by Wei Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Deng. The network helps show where Wei Deng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wei Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Deng Line = papers co-authored together Wei Deng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	U (uranium)-polymetallic mineral systems in the world: Genetic types, metallogenic settings and ore-forming mechanisms, and perspective for exploration Science China Earth Sciences ·Deru Xu, Chanjuan Wang, Bin Li, Guoxiang Chi, Yang Cui, Wei Deng, Wenhao Li, Ying Li, W. Haetscher, Dr.C. Ramesh, Xuehuan Huang, Shaohao Zou, Teng Deng, Catherine Pravisay-Malmstadt	2025	1
2	Shenling Tongqiao powder targets TGF-β1/Smad-Wnt/β-catenin axis to suppress epithelial-mesenchymal transition in chronic rhinosinusitis Phytomedicine ·Kai Liu, Hui Zeng, Xiao Zhu, Hao Deng, Wei Deng, Tariq Aljasser, Feier Liu, Bin Ji, Shuai Lü, Wei Wu, Qi Wu, Jun Liao, TD Due, امید بزرگ حداد, Y S Ying, Ying Wang, Tess Maureen Mayer	2025	0
3	Immunotherapy concurrently administered with chemoradiotherapy in limited-stage small-cell lung cancer BMC Cancer ·Joy D. Morrow, Yeqing Sun, R. Kuppen, June Booth, Aaron Zellner, Yuting Zhao, Wei Deng, Jiayi Yu, Xiao Chang, Anhui Shi, Rong Yu, Huiming Yu	2025	0
4	A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy Journal of Colloid and Interface Science ·Zainab Mohammed AlSaeed, Pedro Henrique Quintão Paiva, JigeeshuV Divatia, Wei Deng, Mohammad Taghinejad, Tao Huang, 登久小山, Yong Wang	2024	8
5	Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future Cell Biology and Toxicology ·Metzner Karin J, Saiyang Xie, Wei Deng	2024	30
6	Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma BMC Cancer ·Toshiya Nishiumi, Wei Deng, 冒继承, Rivera de Velásquez, Jin Xie, H Taylor, Dongkuan Liu, Gede Eka Budi Dharmawan, Zhigao Hu, Renfeng Shan	2024	5
7	Pathologic complete response to chemoimmunotherapy of an advanced gastric cancer patient with high PD-L1 expression, dMMR, and unique gut microbiota composition: A case report Frontiers in Oncology ·Hongpeng Jiang, Junyun Wang, Wei Deng	2023	1
8	Doxorubicin-induced Chronic Heart Failure is Alleviated by Gentiopicroside by Inhibiting Oxidative Stress and Inflammation Indian Journal of Pharmaceutical Education and Research ·Alvaro Blázquez, Pan Gao, Wei Deng, Shujun Wang	2023	2
9	Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer Journal of Cancer Research and Clinical Oncology ·Yang Zhao, Rong Yu, Wei Deng, Weihu Wang	2021	2
10	Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002) Gynecologic Oncology ·Alessandro D. Santin, Wei Deng, Michael Frumovitz, Natália Buza, Stefania Bellone, Warner K. Huh, Samir N. Khleif, Heather A. Lankes, Elena Ratner, Roisin E. O’Cearbhaill, Amir A. Jazaeri, Michael J. Birrer	2020	112
11	The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy Radiotherapy and Oncology ·Wei Deng, Xu Cai, Amy Liu, Peter S.N. van Rossum, Weiye Deng, Zhongxing Liao, Albert C. Koong, Radhe Mohan, Steven H. Lin	2019	56
12	<p>Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma</p> Cancer Management and Research ·Meng‐Xin Tian, María Fernanda Olivares, Wei‐Ren Liu, Wei Deng, Jiacheng Yin, Lei Jin, Xi‐Fei Jiang, Yufu Zhou, Wei‐Feng Qu, Zheng Tang, Han Wang, Arnaud D'agnel, Yuan Fang, Shuang–Jian Qiu, Jian Zhou, Jingfeng Liu, Jia Fan, Ying‐Hong Shi	2019	14
13	NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer Radiotherapy and Oncology ·Mélissa Thomas, Gilles Defraene, Maarten Lambrecht, Wei Deng, Johnny Moons, Philippe Nafteux, Steven H. Lin, Karin Haustermans	2019	34
14	Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study Gynecologic Oncology ·Amina Ahmed, Wei Deng, William P. Tew, David Bender, Robert S. Mannel, Ramey D. Littell, Albert S. DeNittis, Mitchell I. Edelson, Mark A. Morgan, Jay W. Carlson, Christopher J. Darus, Jingyue Xie, Susan C. Modesitt, Alexander Olawaiye, Anthony C. Evans, Gini F. Fleming	2018	14
15	SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis Journal of Clinical Oncology ·Ruben A. Mesa, Jean‐Jacques Kiladjian, John Catalano, Timothy Devos, Miklós Egyed, 和義武田, Donal P. McLornan, Kazuya Shimoda, Elliott F. Winton, Wei Deng, Ronald L. Dubowy, Julia D. Maltzman, Francisco Cervantes, Jason Gotlib	2017	238
16	Symptom cluster of patients with head and neck cancer The Journal of practical nursing ·Wei Deng, Atushi Fusegi, Dandan Liu	2015	0
17	Impact of gender on the clinicopathological features of patients with primary IgA nephropathy Wei Deng, Qian Zhou, Wenting Liu, Aduthotla Ramesh, Wei Chen, Xueqing Yu, Elif İlkay Yüce	2015	1
18	Long‐term safety and efficacy of deferasirox (Exjade^®) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease British Journal of Haematology ·Elliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, Renée V. Gardner, T Tsurugai, Matthew M. Heeney, Baba Inusa, Abdullah Kutlar, Peter A. Lane, Liesl Mathias, John B. Porter, Cameron K. Tebbi, Felicia Wilson, Louis Griffel, Wei Deng, Vanessa Giannone, Thomas D. Coates	2011	58
19	Management of High-Flow Arteriovenous Malformation in the Maxillofacial Region Journal of Craniofacial Surgery ·Wei Deng, 建設省都市計画課, Ataka Shin-ichiro, Xing Zhang, Jennifer Charlson, Jianping Li, 一巳藤倉	2010	14
20	Two-Phased Parking Choice Model for Pre-trip Parking Guidance System Transportation Research Board 86th Annual MeetingTransportation Research Board ·Yanjie Ji, Wei Deng, Wei Wang, Guangrong Liu	2007	3

About Wei Deng

Wei Deng is a scholar working on Obstetrics and Gynecology, Pulmonary and Respiratory Medicine, Radiation, Reproductive Medicine and Oncology, having authored 93 papers that have together received 1.4k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (20 papers), Gastric Cancer Management and Outcomes (15 papers), Esophageal and GI Pathology (12 papers), Endometrial and Cervical Cancer Treatments (10 papers), Radiation Therapy and Dosimetry (8 papers), Ovarian cancer diagnosis and treatment (7 papers), Advanced Radiotherapy Techniques (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Genetics (330 citations), Hematology (293 citations), Radiation (187 citations), Obstetrics and Gynecology (142 citations) and Oncology (401 citations). Wei Deng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Steven H. Lin, Jason Gotlib, Timothy Devos, Elliott F. Winton, Francisco Cervantes, Donal P. McLornan, Ruben A. Mesa, John Catalano, Jean‐Jacques Kiladjian and Julia D. Maltzman. Their work appears in journals such as Gynecologic Oncology, Journal of Clinical Oncology, Blood, Medical Physics and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact